Vaccines containing Hepatitis B S-protein
US5196194A · kind A · utility
27Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 1984 |
| Grant date | Mar 23, 1993 |
| Priority date | — |
| Expiry date | Dec 7, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant full-length Hepatitis B surface antigen protein is disclosed. This protein is useful in vaccines for the prevention of Hepatitis B infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.